One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and The Lancet.
https://www.nytimes.com/2018/09/08/...ghlights&contentPlacement=1&pgtype=collection
https://www.nytimes.com/2018/09/08/...ghlights&contentPlacement=1&pgtype=collection